A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects

PHASE4RecruitingINTERVENTIONAL

Enrollment

320

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Cataract

Interventions

DEVICE

Clareon PanOptix

Bilateral Clareon PanOptix IOL implantation

DRUG

Clareon PanOptix PRO

Bilateral Clareon PanOptix PRO IOL implantation

DRUG

Mix-and-Match PanOptix/Vivity

Clareon PanOptix Pro in the non-dominant eye and Clareon Vivity in the dominant eye

Trial Locations (2)

RECRUITING

Shafer Vision Institute, Plymouth Meeting

RECRUITING

Berkeley Eye Center, Houston

All Listed Sponsors

collaborator

Sengi

INDUSTRY

lead

Berkeley Eye Center

OTHER